Consolidated figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,020 | 966 | 1,074 | 1,024 | 1,045 | 1,057 | 1,051 | 1,038 | 1,121 | 1,051 | 1,179 | 1,300 | |
| COGS | 505 | 509 | 596 | 529 | 507 | 539 | 533 | 519 | 601 | 556 | 619 | 629 |
| Gross profit | 515 | 458 | 479 | 496 | 538 | 518 | 518 | 519 | 520 | 495 | 560 | 672 |
| 397 | 362 | 387 | 386 | 414 | 380 | 372 | 376 | 385 | 368 | 397 | 473 | |
| 118 | 96 | 91 | 110 | 125 | 138 | 147 | 142 | 135 | 127 | 163 | 199 | |
| OPM % | 11.6% | 9.9% | 8.5% | 10.7% | 11.9% | 13.1% | 14% | 13.7% | 12.1% | 12% | 13.8% | 15.3% |
| Depreciation | 34 | 34 | 36 | 39 | 40 | 40 | 39 | 41 | 41 | 45 | 48 | 51 |
| Interest | 13 | 15 | 14 | 14 | 15 | 12 | 14 | 13 | 12 | 12 | 12 | 17 |
| 9 | 9 | 10 | 10 | 10 | 9 | 8 | 11 | 11 | -4 | 9 | 10 | |
| Profit before tax | 80 | 55 | 51 | 66 | 80 | 96 | 102 | 100 | 93 | 65 | 112 | 141 |
| Tax | 22 | 17 | 22 | 17 | 21 | 26 | 28 | 25 | 23 | 19 | 25 | 35 |
| Tax % | 28% | 30% | 43% | 26.2% | 26.5% | 27.4% | 27.3% | 24.7% | 25.2% | 28.3% | 22.6% | 24.9% |
| 57 | 39 | 29 | 49 | 59 | 69 | 74 | 75 | 69 | 47 | 86 | 106 | |
| PAT margin % | 5.6% | 4% | 2.7% | 4.8% | 5.6% | 6.6% | 7% | 7.2% | 6.2% | 4.5% | 7.3% | 8.1% |
| EPS (₹) | 3.6 | 2.4 | 1.9 | 3.1 | 3.7 | 4.4 | 4.7 | 4.8 | 4.4 | 3 | 5.5 | 6.7 |
| Results filing | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | -21.8% | -16.6% | -6.2% | -4.7% | +2.5% | +9.4% | -2.2% | +1.3% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Speciality Chemicals | 637 | 109.14 | 3,170.63 | 736.22 | 2,434.41 |
| Chemical Intermediates | 525.17 | 43.97 | 1,571.39 | 605.35 | 966.04 |
| +7.2% |
| -0.5% |
| +12.1% |
| +25.3% |
| PAT YoY % | -31.8% | -57.9% | -44.1% | -15.4% | +2.6% | +79.9% | +153.2% | +54.1% | +17.7% | -32.4% | +16.7% | +40.9% |
| Nutrition & Health Solutions | 243.82 | 28.26 | 901.31 | 168.53 | 732.78 |
₹ crore by quarter